Avenda Health
Image guided laser therapy for prostate cancer in a doctor’s office.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 20.0x EV/Revenue | round | |
* | N/A | $1.2m | Debt |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 40 % | - | 493 % | 14 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Avenda Health is a medical technology company focused on personalized prostate cancer care. The company has developed Unfold AI, an FDA-cleared platform that uses deep learning to create a 3D map of a patient's cancer. This technology provides physicians with a detailed visualization of the tumor, enabling more precise and targeted treatment.
The company's approach aims to improve patient outcomes by preserving quality of life. By accurately mapping the cancer, Avenda Health's platform facilitates a minimally invasive laser ablation procedure that can be performed in a doctor's office under local anesthesia. This procedure, described as a male 'lumpectomy,' targets the cancerous tissue while minimizing damage to surrounding healthy tissue.
Avenda Health's business model is centered on providing its Unfold AI platform to healthcare providers, including hospitals and clinics. The company has recently secured $10 million in Series B funding to further develop its technology and expand its reach within the prostate cancer treatment market.
Keywords: prostate cancer, medical technology, AI, deep learning, 3D mapping, laser ablation, minimally invasive, oncology, medical imaging, personalized medicine